These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9501

  • 1. [Synthesis of 5-(3-tert-butylamino-2-hydroxypropoxy)-8-hydroxy-3,4-dihydrocarbostyril hydrochloride and its beta-adrenergic blocking activity].
    Uchida M, Tominaga M, Oka K, Tone H, Uno T.
    Yakugaku Zasshi; 1976 May; 96(5):571-7. PubMed ID: 9501
    [No Abstract] [Full Text] [Related]

  • 2. [Syntheses of 8-acylamino-3,4-dihydrocarbostyril derivatives with beta-adrenergic blocking action].
    Oshiro Y, Watanabe K, Nakagawa K.
    Yakugaku Zasshi; 1984 Jan; 104(1):28-36. PubMed ID: 6145784
    [No Abstract] [Full Text] [Related]

  • 3. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
    Nakagawa K, Murakami N, Yoshizaki S, Tominaga M, Mori H.
    J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
    [No Abstract] [Full Text] [Related]

  • 4. Syntheses and beta-adrenergic blocking activities of the optical isomers of 8-acetonyloxyl-5-[3-(3,4-dimethoxyphenethylamino)-2-hydroxypropoxy]-3,4-dihydrocarbostyril.
    Yo E, Nakagawa K, Hoshino Y.
    Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2157-60. PubMed ID: 6119164
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis and beta-adrenergic blocking action of a new thiazolylthiopropanolamine derivative.
    Hara Y, Sato E, Miyagishi A, Aisaka A, Hibino T.
    J Pharm Sci; 1978 Sep; 67(9):1334-5. PubMed ID: 29117
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Adrenergic beta-receptor blocking activity of (3-amino-2-hydroxy)propoxy-3, 4-dihydrocarbostyril derivatives in anesthetized dog (author's transl)].
    Nakagawa K, Murakami N, Yoshizaki S, Tominaga M, Mori H.
    Yakugaku Zasshi; 1974 May; 94(5):613-6. PubMed ID: 4153735
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
    Augstein J, Cox DA, Ham AL, Leeming PR, Snarey M.
    J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
    [No Abstract] [Full Text] [Related]

  • 11. Beta-adrenergic blocking agents: substituted phenylalkanolamines. Effect of side-chain length on beta-blocking potency in vitro.
    Fuhrer W, Ostermayer F, Zimmermann M, Meier M, Müller H.
    J Med Chem; 1984 Jul; 27(7):831-6. PubMed ID: 6145802
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Unambiguous synthesis of 1-(7-indenyloxy)-3-isopropylamino-2-propanol hydrochloride and its 4-indenyloxy isomer, potent beta-adrenergic blocking agents.
    Murase K, Tamazawa K, Mase T, Tachikawa S, Shiobara Y.
    Chem Pharm Bull (Tokyo); 1976 Mar; 24(3):552-4. PubMed ID: 14788
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function.
    Erhardt PW, Woo CM, Anderson WG, Gorczynski RJ.
    J Med Chem; 1982 Dec; 25(12):1408-12. PubMed ID: 6130154
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
    Meyer RF, Stratton CD, Hastings SG, Corey RM.
    J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.